Use of nano-immuno assay to generate rapid, quantitative nanoscale proteomic profiling of the hypoxia pathway in renal cell carcinoma clinical specimens.
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Stanford Cancer Institute, Stanford University, Stanford Medicine
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2966291535
